Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease

Circulation

Volumn 99, Issue 6, 1999, Pages 807-812

  Bhat, Hari K ^a   Hiatt, William R ^b   Hoppel, Charles L ^c   Brass, Eric P ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Aging; Metabolism; Peripheral vascular disease

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; CLAUDICATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE TOLERANCE; GASTROCNEMIUS MUSCLE; GENE DELETION; HUMAN; HUMAN TISSUE; MUTATION RATE; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0032934572     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.6.807     Document Type: Article

References (42)

1. Criqui MH, Franek A, Barrett-Conner E, Klouber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-515.
2. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg. 1996;23:104-115.
3. Hiatt WR, Marshall JA, Baxter J, Sandoval R, Hildebrandt W, Kahn LR, Hamman RF. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol. 1990;43:597-606.
4. Pernow B, Zelterquist S. Metabolic evaluation of the leg blood flow in claudication patients with arterial obstruction at different levels. Scand J Clin Lab Invest. 1968;21:277-287.
5. Jansson E, Johansson J, Sylven C, Kaiijser L. Calf muscle adaptation in intermittent claudication: side-differences in muscle metabolic characteristics in patients with unilateral arterial disease. Clin Physiol. 1988;8: 17-29.
6. Hiatt WR, Wolfel EE, Regensteiner JE, Brass EP. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol. 1992;73:346-353.
7. Brass EP. Skeletal muscle metabolism as a target for drug therapy in peripheral arterial disease. Vasc Med. 1996;1:55-59.
8. Lundgren F, Dahllof A-G, Schersten T. Bylund-Fellenius A-C. Muscle enzyme adaptation in patients with peripheral arterial insufficiency: spontaneous adaptation, effect of different treatments and consequences on walking performance. Clin Sci. 1988;77:485-493.
9. Bylund AC, Hummarsten J, Holm J, Schersten T. Enzyme activities in skeletal muscles from patients with peripheral arterial insufficiency. Eur J Clin Invest. 1976;6:425-429.
10. Hiatt WR, Nawaz D, Brass EP. Carnitine metabolism during exercise in patients with peripheral vascular disease. J Appl Physiol. 1987;62: 2382-2387.
11. 31P magnetic resonance spectroscopy of abnormal mitochondria oxidation in skeletal muscle during recovery from exercise. NMR Biomed. 1993;6:302-310.
12. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990;81:602-609.
13. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol. 1996;81:780-788.
14. Wallace DC. Diseases of the mitochondrial DNA. Ann Rev Biochem. 1992;61:1175-1212.
15. Tritsehler H-J, Medori R. Mitochondrial DNA alterations as a source of human disorders. Neurology. 1993;43:280-288.
16. Anderson S, Bankier AT, Barrell BG, de Druijin MHL, Coulson AR, Brown J, Eperson IC, Nierlich DP, Rue BA, Sanger F, Schreier PH, Smith ASH, Staden R, Young IG. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457-460.
17. Schon EA, Rizzuto R, Moracs CT, Nakase H, Zeviani M, DiMauro S. A direct repeat is a hot spot for large scale deletion of human mitochondrial DNA. Science. 1989;244:346-349.
18. Johns DR, Rutledge SL, Stine OC, Hurko O. Directly repeated sequences associated with pathogenic mitochondrial DNA deletions. Proc Natl Acad Sci U S A. 1989;174:1324-1330.
19. Corral-Debrinski M, Stepian G, Shoffner JM, Lott MT, Keuter K, Wallace DC. Hypoxemia is associated with mitochondrial DNA damage and gene induction. JAMA. 1991;266:1812-1816.
20. Yamamoto H, Tanaka M, Katayama M, Obayashi T, Nimura Y, Ozawa T. Significant existence of deleted mitochondrial DNA in cirrhotic liver surrounding hepatic tumor. Biochem Biophys Res Commun. 1992;182: 913-920.
21. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutation Res. 1992;275:169-180.
22. Grossmann LI. Mitochondrial DNA in sickness and in health. Am J Hum Genet. 1990;46:415-417.
23. Muller-Mocker J. Mitochondria and aging. Brain Pathol. 1992;2: 149-158.
24. Cooper JM, Mann VM, Schapira AHV. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of aging. J Neurol Sci. 1992;113:91-98.
25. Kadenbach B, Munscher C, Frank V, Muller-Hocker J, Napiwotzki J. Human aging is associated with stochastic somatic mutations of mitochondrial DNA. Mutat Res. 1995;338:161-172.
26. Belch JJF, Chopra M, Hutchison S, Lorimer R, Sturrock RD, Forbes CD, Smith WE. Free radical pathology in chronic arterial disease. Free Radic Biol Med. 1989;6:375-378.
27. Belch JJF, Mackey IR, Hill A, Jennings P, McCollum P. Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus. Int Angiol. 1995;14:385-388.
28. Hiatt WR, Huag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley diabetes study. Circulation. 1995;91:1472-1479.
29. Whipp BJ, Ward SA, Lamara N, Davis JA, Wasserman K. Parameters of ventilatory and gas exchange dynamics during exercise. J Appl Physiol. 1982;52:1506-1513.
30. Zhang H, Cooney DA, Sreenath A, Zhan Q, Agbaria R, Stowe EE, Fornace AJ, Johns DG. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content. Mol Pharmacol. 1994;46:1063-1069.
31. Srere PA. Citrate synthase. Methods Enzymol. 1969;13:3-11.
32. Wharton DC, Tzagoloff A. Cytochrome oxidase. Methods Enzymol. 1967;10:245-250.
33. Lilienthal JL Jr, Zierler KL, Folks BP, Buka R, Riley MJ. A reference base and system for analysis of muscle constituents. J Biol Chem. 1950; 182:501-508.
34. Williams R. Mitochondrial gene expression in mammalian striated muscle: evidence that variation in gene dosage is the major regulatory event. J Biol Chem. 1986;261:12390-12394.
35. Puntschart A, Claassen H, Jostarndt K, Hoppeler H, Billeter R. mRNAs of enzymes involved in energy metabolism and mtDNA are increased in endurance-trained athletes. Am J Physiol. 1995;269:C619-C625.
36. Egawhary DN, Swobodn EP, Chen J, Vince FP. Damage to the vascular endothelium of diabetic patients can be assessed by analyzing blood samples for the number of circulatory endothelial cells with mitochondrial DNA deletions. Biochem Soc Trans. 1995;23:402S. Abstract.
37. Ames BN, Shigenaga MK, Huges TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA. 1993;90: 7915-7922.
38. Karmazyn M. Ischemic and reperfusion injury in the heart: cellular mechanisms and pharmacological interventions. Can J Physiol Pharmacol. 1991;69:719-730.
39. Turrens JF, Beconi M, Barilla J, Chavez UB, McCord JM. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radic Res Commun. 1991;12:681-689.
40. Ballinger SW, Bouder TG, Davis GS, Judice SA, Nicklas JA, Albertini RJ. Mitochondrial genome damage associated with cigarette smoking. Cancer Res. 1996;56:5692-5697.
41. Davies KJA, Packer L, Brooks GA. Biochemical adaptation of mitochondria, muscle, and whole-animal respiration to endurance training. Arch Biochem Biophys. 1981;209:539-554.
42. Hoppel CL, Kerr DS, Dahms B, Roessmann U. Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. J Clin Invest. 1987; 80:71-77.